Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
and exhibit significant efficacy in PTEN- and PI3K mutant xenograft models
H2O : 50 mg/mL (109
4-triazol-1-yl)methyl]-1
which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia
InChi: InChI=1S/C26H31Cl2N7O3/c1-5-34-10-12-35(13-11-34)18-8-6-17(7-9-18)31-21-15-22(30-16-29-21)33(2)26(36)32-25-23(27)19(37-3)14-20(38-4)24(25)28/h6-9
9-cis-β-Carotene ase Inhibitor I G5 and exhibit significant efficacy in9 cis Carotene, a precursor of retinal, is cleaved by beta carotene oxygenase 1 (BCMO1) to produce 9 cis retinal. 9 cis Carotene inhibits photoreceptor degeneration and restores retinal function in vivo. 9 cis Carotene has the potential for the study of congenital stationary night blindness and fundus albipunctatus. Product information CAS Number: 13312 52 2 Molecular Weight: 536. 87 Formula: C40H56 Chemical Name: 1,3,3 trimethyl 2